A study lead by researchers from Mayo Clinic suggests remission from Crohn’s disease may be more likely if patients receive biologic therapy combined with immune-suppressing drugs first instead of ...

Here's part of interesting release that rolled out of Mayo Clinic this morning…before the communications office open. Somebody has learned how to automate. Heh. Centocor, Inc. is the company that ...

ROCHESTER, Minnesota — Inflammatory bowel disease (IBD) is a chronic inflammation of the digestive tract. It includes conditions such as ulcerative colitis and Crohn's disease. In this expert alert, ...

The new molecules selectively reduced inflammatory signaling in human immune cells without affecting other immune pathways. Treatment with the molecules also reduced inflammation in mice with the ...

SAN DIEGO — Crohn’s disease (CD) has become more common in the United States, and an estimated 1 million Americans have the condition. Still, much is unknown about how to evaluate the individual risk ...

Sold in pill form, the JAK inhibitor Rinvoq (upadacitinib) offers a new, fast-acting alternative to infusions and injectable drugs. On May 18, the U.S. Food and Drug Administration (FDA) granted ...